Trials / Conditions / Neurofibromatosis Type 1 (NF1)
Neurofibromatosis Type 1 (NF1)
4 registered clinical trials studyying Neurofibromatosis Type 1 (NF1) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas NCT06961565 | Pasithea Therapeutics Corp. | Phase 1 |
| Active Not Recruiting | MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofi NCT03962543 | SpringWorks Therapeutics, Inc. | Phase 2 |
| Terminated | Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1) NCT01968590 | University of Utah | Phase 2 |
| Completed | Precision Medicine for Neurocutaneous Syndromes in Western China NCT07327164 | West China Hospital | — |